Clinical Trial: Phase I PK Study of Budesonide/Albuterol Delivered From PT027 in Healthy Chinese Participants.
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Healthy Volunteer
Study Type: INTERVENTIONAL
Official Title: A Phase I, Open-Label, Single-dose, Single Arm Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Budesonide and Albuterol Delivered by PT027 in Healthy Chinese Participants
Brief Summary:
A phase I study to assess the PK, safety, and tolerability of budesonide and albuterol delivered from a single dose of BDA MDI administered by inhalation in healthy Chinese participants.
Read more